Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234
for
Atopic Dermatitis (AD), Eczema
Location: Fair Lawn NJ, Plainfield IN, College Station TX,
Sponsor: Arcutis Biotherapeutics, Inc.
Sex: All
Age: 18 - 65
Code: NCT07453602
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Investigate the Safety, Tolerability, and Efficacy of BxC-I17e Single and Multiple Dose SC Injection in Patients With Moderate to Severe Atopic Dermatitis
for
Atopic Dermatitis
Location: Philadelphia PA, Camp Hill PA, North Little Rock AR
Sponsor: Brexogen Inc.
Sex: All
Age: 18+
Code: NCT06055361
Phase1, Recruiting
Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis
for
Atopic Dermatitis
Location: Webster TX, Bellaire TX, Fountain Valley CA,
Sponsor: Oneness Biotech Co., Ltd.
Sex: All
Age: 18 - 65
Code: NCT06397911
Phase2, Recruiting
Ethnic Differences in Mechanisms of Action of Dupilumab
for
Atopic Dermatitis
Location: Ann Arbor MI
Sponsor: University of Michigan
Sex: All
Age: 18+
Code: NCT05268107
Recruiting
Monitoring Pregnancy and Infant Outcomes Following Tralokinumab Exposure During Pregnancy in the US and Canada - PROTECT
for
Atopic Dermatitis, Eczema
Location: La Jolla CA
Sponsor: University of California, San Diego
Sex: Female
Age: 0+
Code: NCT05938478
Recruiting
Skin Barrier Abnormalities and Oxidative Stress Response